Hansoh Pharmaceutical Group Company Limited (3692.HK)

HKSE · Healthcare · Drug Manufacturers - Specialty & Generic
30.74 HKD-5.18%As of 2026-11-22 · HKD
Last session low 30.60 HKDLast session high 32.10 HKD
52-week low 28.06 HKD52-week high 44.22 HKD
Market cap (USD)
$23.77B
Sector
Healthcare
P/E (TTM)
25.0x
Dividend yield
1.58%

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in HKD.

IndicatorValueReading
RSI (14)36.2In the neutral range (30 to 70)
MACD (12, 26, 9)-0.17Below its signal line (0.12); histogram -0.30
Bollinger %B (20, 2)-1%Below the lower band (30.78 to 35.93)
SMA 2033.36Price is 7.9% below
SMA 5033.41Price is 8.0% below
SMA 20033.77Price is 9.0% below
ATR (20)4.36% of priceAverage true range per day
52-week position17%In the lower part of the 28.06 to 44.22 range

About Hansoh Pharmaceutical Group Company Limited

Hansoh Pharmaceutical Group Company Limited, an investment holding company, engages in the research, development, production, and sale of pharmaceutical products in the People's Republic of China. The company provides products for therapeutic areas, including anti-infection, central nervous system, oncology, and metabolic and other diseases, as well as autoimmune diseases.

Latest fiscal yearEnded 2025-12-31: revenue of 15.03B CNY and an operating margin of 36.9%.

More in Drug Manufacturers - Specialty & Generic